Euro area | Immunization, DPT (% of children ages 12-23 months)

Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Euro area
Records
63
Source
Euro area | Immunization, DPT (% of children ages 12-23 months)
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980 33.95923551
1981 57.08467505
1982 59.80907645
1983 60.24402053
1984 74.50151801
1985 68.93285563
1986 74.57238868
1987 69.50275501
1988 69.313068
1989 72.66054744
1990 85.42106264
1991 88.77570579
1992 89.52049779
1993 82.9593532
1994 88.6889032
1995 90.08339002
1996 92.02318601
1997 92.66707529
1998 92.74049326
1999 95.01727973
2000 92.56307947
2001 94.52488739
2002 94.82865942
2003 96.43802133
2004 95.89659939
2005 95.93161865
2006 96.7581805
2007 96.82649903
2008 96.8207481
2009 96.42105388
2010 96.88645904
2011 96.74345393
2012 96.90852455
2013 96.39175022
2014 96.10209388
2015 95.3014374
2016 94.49448687
2017 94.3125528
2018 94.21650696
2019 94.26894596
2020 93.83813186
2021 93.60598868
2022 93.68730249

Euro area | Immunization, DPT (% of children ages 12-23 months)

Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Euro area
Records
63
Source